论文信息 - Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA). - 字舞流文

Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA).

J. Mellors | M. Boffito | D. Back | U. Parikh | L. Else | A. Jackson | Kerri J. Penrose | Kristen A. Hamanishi